StockTipsArenaBeta

BUY Gland Pharma Limited — Aamar Deo Singh, Angel One

BUYGland Pharma Limited
Gland Pharma share price target & all analyst calls

byAamar Deo Singh, Angel OneHorizon: NA (inferred 1 year)11 Aug 2026via CNBC Awaaz.

Entry₹2,876Inferred
Target₹3,200
Total upside +11.27% (call closed)
Stop lossNot given
Exit₹3,2005 Nov 2026, 10:46 am
Target hit+11.27%0.00%upside left
Follow Aamar Deo Singh for new callsGet alertsWatch GLAND for new buy/sell callsGet alertsSee 11 active Long-term calls on GLANDSee 273 active Long-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 5 Nov 2026
25 supporting12 neutral5 opposing
Supports the BUY call (25)

Gland Pharma has received regulatory approval for its Methylprednisolone Acetate Injectable Suspension USP in both single and multiple dose vials.

BSE · Company Update·3 Nov · yesterday

(opens in new tab)

Gland Pharma received US FDA approval for its Methylprednisolone Acetate Injectable Suspension, used for various inflammatory and allergic conditions.

NSE · Press Release·3 Nov · yesterday

(opens in new tab)

3 advisors have active short-term BUY calls on this stock

Advisor consensus · adjacent horizon·13 Oct · 3w ago

Gland Pharma sets e-voting for Wang appointment; $21m US investment approved

NewsGoogle News·6 Oct · 4w ago

(opens in new tab)

5 other SEBI-registered advisors have active long-term BUY calls on this stock

Advisor consensus · same horizon·7 Oct · 4w ago

Neutral / worth noting (12)

Gland Pharma USFDA Inspection Dundigal Facility 2026

NewsGoogle News·23 Oct · 2w ago

(opens in new tab)
Weighs against the BUY call (5)

2 other SEBI-registered advisors have active long-term SELL calls on this stock

Advisor consensus · same horizon·12 Aug · 3mo ago

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Gland Pharma

All analyst calls on Gland Pharma

More from Aamar Deo Singh, Angel One

Every call and its outcome